Evaluation of the Response to Monoclonal Antibody Therapy in Severe Asthma: Research of Predictive Biomarkers in Exhaled Air
NCT03988790
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Asthma
Interventions
DEVICE:
VOC analysis
Sponsor
Hopital Foch